Lonza Snaps Up KKR-Backed Capsugel In $5.5B Deal
Lonza inked a $5.5 billion, including debt, deal to nab capsule product maker Capsugel from KKR on Thursday, as the Switzerland-based pharmaceutical products company looks to broaden its reach in the...To view the full article, register now.
Already a subscriber? Click here to view full article